Terumo Corp.

Terumo Corp.

Terumo Corp.

Overview
Date Founded

1921

Headquarters

2-44-1 Hatagaya, Shibuya-ku, Tokyo, 151-0072, JPN

Type of Company

Public

Employees (Worldwide)

23.3K

Industries

Industrial Machinery & Manufacturing
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services

Company Description

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: General Hospital, Cardiac & Vascular, and Blood Management. The General Hospital segment produces, supplies, leases, and sells hospital equipment, pharmaceutical, home medical treatment, and peritoneal dialysis and diabetes-related products. The Cardiac & Vascular segment imports and merchandises catheter and cardiovascular systems products. The Blood Management segment manufactures and sells blood transfusion products such as blood bags and automated blood component processing devices. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan

Executives & Employees

President & Chief Executive Officer

Chairman

Senior Executive Officer & General Manager, Research & Development

Chief Technology Officer, Executive Officer, GM-Research & Development

General Manager-Sales Management Department

Chief Legal Officer & General Manager-Compliance

Executive Officer & Head-Healthcare Company

Head-Investor Relations, Legal & Compliance

Chief Accounting & Financial Officer

Chief Clinical & Regulatory Affairs Officer

Board of Directors

Chairman at Terumo Corp.

Partner at Mori Hamada & Matsumoto

President & Chief Executive Officer at Terumo Corp.

President & Chief Executive Officer at Terumo BCT Holding Corp.

Senior Executive Officer & General Manager, Research & Development at Terumo Corp.

Auditor at Terumo Corp.

Former Chairman & Chief Executive Officer at Subaru Corp.

Director & Managing Executive Officer at Terumo Corp.

Paths to Terumo Corp.
Potential Connections via
Relationship Science
You
Terumo Corp.
Owners & Shareholders
Details Hidden

NAM-J is an active, value-oriented manager with a global perspective and a medium- to long-term outlook. Their investment philosophy emphasizes multi-faceted research shared internationally throughout the group, and local expertise contributed by their overseas offices. Their strong research capabilities, supported and integrated globally by proprietary systems, include fundamental analysis, company visits, market research, credit analysis, macroeconomic projections and quantitative analysis. Their global asset allocation strategy is determined by an investment committee at the group level.The firm uses a variety of strategies including active, passive and active quantitative. Their funds are invested in domestic and global equity and fixed-income, as well as in Japanese money market instruments. The majority of their investments are in equity, complemented by a substantial minority of bonds and investments in private placement funds. The firm manages a range of Japanese ETFs including sector funds.NAM-J's investment process is team-based and combines bottom-up and top-down strategies, with a bias towards stockpicking.

Details Hidden

Asset Management One is a forward-thinking and progressive manager which seeks to help customers build assets in the long term and aims to provide global asset management by quickly responding to constantly changing market circumstances and regulatory trends.The firm seeks to efficiently predict socioeconomic or market changes in order to identify appropriate asset management-based solutions.

Details Hidden

Nikko AM is an active, growth-oriented manager which follows a range of active and passive equity, fixed-income, and alternative investment strategies, investing primarily in Japanese equity, fixed-income, money market instruments and REITs. Through their overseas offices they invest globally, favoring Asian equity and US mid- and large-cap companies, as well as emerging markets. Their alternative investments follow strategies such as global fixed-income and currency arbitrage, Japanese market neutral, convertible bond and option-based arbitrage strategies, and multi-manager funds.The firm seeks to identify good companies at an early stage and follows a bottom-up approach based on in-house research. Their investment criteria at the company level include managerial execution, product development and cost competitiveness. Fixed-income investments comprise domestic and global bond funds with a currency overlay.Nikko AM's research capabilities combine fundamental analysis coverage with advanced quantitative techniques. Autonomous investment teams integrate research functions and focus on specific investment or regional strategies.

Recent Transactions
Details Hidden

Terumo Corp. purchases Bolton Medical, Inc. from Werfen Group SA

Details Hidden

Terumo Corp. purchases Abbott Laboratories /Medical Device Business from Abbott Laboratories

Details Hidden

MicroVention, Inc., Terumo Corp. purchase Sequent Medical, Inc. from Domain Associates LLC, U.S. Venture Partners, Versant Venture Management LLC, Delphi Ventures, Inc.

Transaction Advisors
Legal Advisor

Advised onTerumo Corp. purchases CaridianBCT, Inc. from Investor AB, EQT Partners AB, Indap Sweden AB

Investment Advisor

Advised onTerumo Corp. purchases Bolton Medical, Inc. from Werfen Group SA

Investment Advisor

Advised onTerumo Corp. purchases CardioVascular Systems, Inc. (Inactive) from 3M Company

Legal Advisor

Advised onTerumo Corp. purchases CaridianBCT, Inc. from Investor AB, EQT Partners AB, Indap Sweden AB

Legal Advisor

Advised onTerumo Corp. purchases CaridianBCT, Inc. from Investor AB, EQT Partners AB, Indap Sweden AB

Legal Advisor

Advised onTerumo Corp., Terumo Medical Corp. purchase Harvest Technologies Corp.

Clients

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 23,500 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext.

FUJIFILM Holdings, Inc. engages in the development, production, sales and service of imaging, information, and document solutions. It operates through the following segments: Imaging Solutions, Information Solutions, and Document Solutions. The Imaging Solutions segment handles color films, digital cameras, optical devices, color paper, services and equipment for photofinishing, instant photo systems, etc. The Information Solutions segment deals with the equipment and materials for medical systems, life sciences products, pharmaceuticals, graphic arts, flat panel display materials, recording media and electronic materials, etc. The Document Solutions segment provides office copy machines/MFPs, printers, production systems and services, office services, paper and consumables, etc. The company was founded on January 20, 1934 and is headquartered in Tokyo, Japan.

Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. Its products include botulinum toxin, hyaluronic acid fillers, facial masks, concealers, and moisturizers. The company was founded on November 22, 2001 and is headquartered in Chuncheon-si, South Korea.

Key Stats and Financials As of 2018
Market Capitalization
$2.24T
Total Enterprise Value
$2.28T
Earnings Per Share
$259.12
Revenue
$588B
Net Profit
$91.3B
EBITDA
$149B
EBITDAMargin
25.35%
Total Debt
$336B
Total Equity
$550B
Enterprise Value Sales
3.88x
Enterprise Value EBITDAOperating
15.31x
TEVNet Income
24.99x
Debt TEV
0.15x
Three Year Compounded Annual Growth Rate Of Revenue
6.29%
Five Year Compounded Annual Growth Rate Of Revenue
7.88%
Investments
Details Hidden

Rethink Medical, Inc. manufactures heart disease medical devices. It produces a remote patient physiologic monitor for predicting heart failure related hospitalizations. The company was founded by Mack Gamahewage, Reza Naima and Vivek Kesaree in 2010 and is headquartered in San Francisco, CA.

Suppliers
Asahi Intecc Co. Ltd. Hospitals & Patient Services | Nagoya, AI

Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical and industrial equipment products. It operates through the Medical and Device segments. The Medical segment deals with the development, manufacture, and sale of self-branded and original equipment manufacturer products of medical equipment. The Device segment involves in the development, manufacture, and sale of parts of medical and industrial equipment. The company was founded on July 8, 1976 and is headquartered in Nagoya, Japan.

TechMatrix Corp. IT Consulting & Services | Tokyo, TY

TechMatrix Corp. engages in the business of information technology solutions and provision of consulting and maintenance services. It operates through the Information Infrastructure Business and Application Services Business segments. The Information Infrastructure Business segment provides cutting-edge integration services for information infrastructure technology that will drive technological innovation in the cloud computing era. The Application Services Business segment provides various application services, leveraging its extensive business process expertise in specific application fields such as systems development, application packages, cloud (SaaS) services, and test solution services. The company was founded on August 30, 1984 and is headquartered in Tokyo, Japan.

Medical Australia Ltd. Medical Products & Equipment | Sydney, NS

Medical Australia Ltd. engages in the development, manufacture and distribution of medical devices and consumables used in the human and animal healthcare markets of Australia, New Zealand and Asia. It focuses on medication delivery, reuse prevention and surgical devices. The company was founded on February 28, 2001 and is headquartered in Sydney, Australia.

Awards & Honors
Rank #14
2011
Forbes Magazine - The Nifty 50
Sponsored by